ESGIAI

• Lower success rate of débridement and implant retention in late acute versus early acute periprosthetic joint infection caused by Staphylococcus spp. results from a matched cohort study.
  Wouthuyzen-Bakker M, Sebillotte M, Huotari K, ESCMID Study Group for Implant-Associated Infections (ESGIAI), et al. Clin Orthop Relat Res 2020. doi: 10.1097/CORR.0000000000001171.
• Propionibacterium/Cutibacterium species-related positive samples, identification, clinical and resistance features: a 10-year survey in a French hospital.
  Broly M, Ruffier d'Epenoux L, Guillouzouic A, et al. Eur J Clin Microbiol Infect Dis 2020; 39:1357-1364. doi: 10.1007/s10096-020-03852-5.
• How to handle concomitant asymptomatic prosthetic joints during an episode of hematogenous PJI, a multicentre analysis.
  Wouthuyzen-Bakker M, Sebillotte M, Arvieux C et al. Clin Infect Dis 2020; ciaa1222. doi: 10.1093/cid/ciaa1222.
• The impact of surgical strategy and rifampin on treatment outcome in Cutibacterium periprosthetic joint infections.
  Achermann Y, Kusejko K, Auñón A et al. Clin Infect Dis 2020; ciaa1839. doi: 10.1093/cid/ciaa1839.
• 2020 Frank Stinchfield Award: Identifying who will fail following irrigation and debridement for prosthetic joint infection.
  Shohat N, Goswami K, Tan T L et al. Bone Joint J 2020; 102-B:11–19. doi:10.1302/0301-620x.102b7.bjj-2019-1628.r1.